biostudies-literatureUnknown43Keefe JA<h4>Background</h4>Coronavirus-2019 (COVID-19) is known to affect the heart and is associated with a pro-inflammatory state. Most studies to date have focused on clinically sick subjects. Here, we report cardiac and proinflammatory biomarkers levels in ambulatory young adults with asymptomatic or mild COVID-19 infection compared to those without infection 4-8 weeks after severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) testing.<h4>Methods</h4>131 asymptomatic or mildly symptomatic subjects were enrolled following testing for SARS-COV-2. Fifty subjects tested negative, and 81 subjects tested positive. Serum samples were collected for measurement of C-reactive protein, ferritin, interleukin-6, NT-pro-B-type natriuretic peptide, and cardiac troponin 28-55 days after SARS-COV-2 RT-International journal of cardiology. Heart & vasculature101144https://www.ebi.ac.uk/biostudies/studies/S-EPMC9613792biostudies-literatureAbnormalities in cardiac and inflammatory biomarkers in ambulatory subjects after COVID-19 infection.PMC9613792Avadhanula VPiedra PAWehrens XHTBozkurt BNicholson EGKeefe JADevaraj SfalseAbnormalities in cardiac and inflammatory biomarkers in ambulatory subjects after COVID-19 infection.<h4>Background</h4>Coronavirus-2019 (COVID-19) is known to affect the heart and is associated with a pro-inflammatory state. Most studies to date have focused on clinically sick subjects. Here, we report cardiac and proinflammatory biomarkers levels in ambulatory young adults with asymptomatic or mild COVID-19 infection compared to those without infection 4-8 weeks after severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) testing.<h4>Methods</h4>131 asymptomatic or mildly symptomatic subjects were enrolled following testing for SARS-COV-2. Fifty subjects tested negative, and 81 subjects tested positive. Serum samples were collected for measurement of C-reactive protein, ferritin, interleukin-6, NT-pro-B-type natriuretic peptide, and cardiac troponin 28-55 days after SARS-COV-2 RT-2022-01-01T00:00:00Z2022 Dec2025-04-26T19:49:25.642Z2024-11-14T03:41:56.926ZS-EPMC96137923632106310.1016/j.ijcha.2022.101144